Literature DB >> 26154167

Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.

Faith A Bazley1, Cyndi F Liu2,3, Xuan Yuan4, Haiping Hao5, Angelo H All1, Alejandro De Los Angeles6,7,8, Elias T Zambidis3,9, John D Gearhart10,11, Candace L Kerr2,12.   

Abstract

Primordial germ cells (PGCs) share many properties with embryonic stem cells (ESCs) and innately express several key pluripotency-controlling factors, including OCT4, NANOG, and LIN28. Therefore, PGCs may provide a simple and efficient model for studying somatic cell reprogramming to induced pluripotent stem cells (iPSCs), especially in determining the regulatory mechanisms that fundamentally define pluripotency. Here, we report a novel model of PGC reprogramming to generate iPSCs via transfection with SOX2 and OCT4 using integrative lentiviral. We also show the feasibility of using nonintegrative approaches for generating iPSC from PGCs using only these two factors. We show that human PGCs express endogenous levels of KLF4 and C-MYC protein at levels similar to embryonic germ cells (EGCs) but lower levels of SOX2 and OCT4. Transfection with both SOX2 and OCT4 together was required to induce PGCs to a pluripotent state at an efficiency of 1.71%, and the further addition of C-MYC increased the efficiency to 2.33%. Immunohistochemical analyses of the SO-derived PGC-iPSCs revealed that these cells were more similar to ESCs than EGCs regarding both colony morphology and molecular characterization. Although leukemia inhibitory factor (LIF) was not required for the generation of PGC-iPSCs like EGCs, the presence of LIF combined with ectopic exposure to C-MYC yielded higher efficiencies. Additionally, the SO-derived PGC-iPSCs exhibited differentiation into representative cell types from all three germ layers in vitro and successfully formed teratomas in vivo. Several lines were generated that were karyotypically stable for up to 24 subcultures. Their derivation efficiency and survival in culture significantly supersedes that of EGCs, demonstrating their utility as a powerful model for studying factors regulating pluripotency in future studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26154167      PMCID: PMC4652187          DOI: 10.1089/scd.2015.0100

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  87 in total

1.  Pluripotential stem cells derived from migrating primordial germ cells.

Authors:  G Durcova-Hills; J Ainscough; A McLaren
Journal:  Differentiation       Date:  2001-10       Impact factor: 3.880

2.  Differential role for transcription factor Oct4 nucleocytoplasmic dynamics in somatic cell reprogramming and self-renewal of embryonic stem cells.

Authors:  Masahiro Oka; Tetsuji Moriyama; Munehiro Asally; Koichi Kawakami; Yoshihiro Yoneda
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

3.  Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus.

Authors:  Pauline T Lieu; Andrew Fontes; Mohan C Vemuri; Chad C Macarthur
Journal:  Methods Mol Biol       Date:  2013

4.  Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.

Authors:  Joyce E Ohm; Prashant Mali; Leander Van Neste; David M Berman; Liang Liang; Kurinji Pandiyan; Kimberly J Briggs; Wei Zhang; Pedram Argani; Brian Simons; Wayne Yu; William Matsui; Wim Van Criekinge; Feyruz V Rassool; Elias Zambidis; Kornel E Schuebel; Leslie Cope; Jonathan Yen; Helai P Mohammad; Linzhao Cheng; Stephen B Baylin
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

5.  The ontogeny of cKIT+ human primordial germ cells proves to be a resource for human germ line reprogramming, imprint erasure and in vitro differentiation.

Authors:  Sofia Gkountela; Ziwei Li; John J Vincent; Kelvin X Zhang; Angela Chen; Matteo Pellegrini; Amander T Clark
Journal:  Nat Cell Biol       Date:  2012-12-16       Impact factor: 28.824

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

Review 7.  Epiblast-derived stem cells in embryonic and adult tissues.

Authors:  Maria P De Miguel; Francisco Arnalich Montiel; Pilar Lopez Iglesias; Alejandro Blazquez Martinez; Manuel Nistal
Journal:  Int J Dev Biol       Date:  2009       Impact factor: 2.203

8.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.

Authors:  Bin-Kuan Chou; Prashant Mali; Xiaosong Huang; Zhaohui Ye; Sarah N Dowey; Linda Ms Resar; Chunlin Zou; Y Alex Zhang; Jay Tong; Linzhao Cheng
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

9.  Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts.

Authors:  James A Byrne; Ha Nam Nguyen; Renee A Reijo Pera
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

10.  Increased reprogramming of human fetal hepatocytes compared with adult hepatocytes in feeder-free conditions.

Authors:  Marc C Hansel; Roberto Gramignoli; William Blake; Julio Davila; Kristen Skvorak; Kenneth Dorko; Veysel Tahan; Brian R Lee; Edgar Tafaleng; Jorge Guzman-Lepe; Alejandro Soto-Gutierrez; Ira J Fox; Stephen C Strom
Journal:  Cell Transplant       Date:  2013-02-04       Impact factor: 4.064

View more
  9 in total

1.  Divergent roles for KLF4 and TFCP2L1 in naive ground state pluripotency and human primordial germ cell development.

Authors:  G V Hancock; W Liu; L Peretz; D Chen; J J Gell; A J Collier; J R Zamudio; K Plath; A T Clark
Journal:  Stem Cell Res       Date:  2021-08-08       Impact factor: 2.020

2.  Primordial germ cell-like cells derived from canine adipose mesenchymal stem cells.

Authors:  Yudong Wei; Jia Fang; Shufang Cai; Changrong Lv; Shiqiang Zhang; Jinlian Hua
Journal:  Cell Prolif       Date:  2016-07-04       Impact factor: 6.831

Review 3.  Pluripotent stem cells: A therapeutic source for age-related macular degeneration.

Authors:  Sowmya Parameswaran; Subramanian Krishnakumar
Journal:  Indian J Ophthalmol       Date:  2017-03       Impact factor: 1.848

4.  H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance.

Authors:  Fei Peng; Ting-Ting Li; Kai-Li Wang; Guo-Qing Xiao; Ju-Hong Wang; Hai-Dong Zhao; Zhi-Jie Kang; Wen-Jun Fan; Li-Li Zhu; Mei Li; Bai Cui; Fei-Meng Zheng; Hong-Jiang Wang; Eric W-F Lam; Bo Wang; Jie Xu; Quentin Liu
Journal:  Cell Death Dis       Date:  2017-01-19       Impact factor: 8.469

5.  Embryonic germ cell extracts erase imprinted genes and improve the efficiency of induced pluripotent stem cells.

Authors:  Jing Hu; Qiaoshi Zhao; Yukuan Feng; Na Li; Yanli Gu; Ruizhen Sun; Lian Duan; Yanshuang Wu; Zhiyan Shan; Lei Lei
Journal:  Sci Rep       Date:  2018-07-19       Impact factor: 4.379

6.  BMP4 activates the Wnt-Lin28A-Blimp1-Wnt pathway to promote primordial germ cell formation via altering H3K4me2.

Authors:  Qisheng Zuo; Kai Jin; Man Wang; Yani Zhang; Guohong Chen; Bichun Li
Journal:  J Cell Sci       Date:  2021-02-01       Impact factor: 5.285

Review 7.  Early Gonadal Development and Sex Determination in Mammal.

Authors:  Yanshe Xie; Changhua Wu; Zicong Li; Zhenfang Wu; Linjun Hong
Journal:  Int J Mol Sci       Date:  2022-07-06       Impact factor: 6.208

Review 8.  Research progress on RNA-binding proteins in breast cancer.

Authors:  Ying Chen; Hai Qin; Lufeng Zheng
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

9.  The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let-7i/TET3 pathway.

Authors:  Yawen Liu; Dawei Wang; Meng Zhou; Hui Chen; Huizhi Wang; Jingyu Min; Jiaxi Chen; Shuhui Wu; Xiufan Ni; Youli Zhang; Aihua Gong; Min Xu
Journal:  Mol Oncol       Date:  2020-11-28       Impact factor: 6.603

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.